Cytogam is a Intravenous Liquid in the Plasma Derivative category. It is labeled and distributed by Csl Behring Ag. The primary component is Human Cytomegalovirus Immune Globulin.
Product ID | 44206-532_d3c9f2f3-23d4-4786-8622-a788381e118d |
NDC | 44206-532 |
Product Type | Plasma Derivative |
Proprietary Name | Cytogam |
Generic Name | Human Cytomegalovirus Immune Globulin |
Dosage Form | Liquid |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2009-01-06 |
Marketing Category | BLA / BLA |
Application Number | BLA103189 |
Labeler Name | CSL Behring AG |
Substance Name | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [EXT],Immunoglobulins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2009-01-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103189 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | ML |
Marketing Start Date | 2009-01-06 |
Marketing Category | BLA |
Application Number | BLA103189 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | ML |
Marketing Start Date | 2012-12-19 |
Ingredient | Strength |
---|---|
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 50 mg/mL |
NDC | Brand Name | Generic Name |
---|---|---|
44206-532 | Cytogam | Human Cytomegalovirus Immune Globulin |
70257-532 | Cytogam | Cytomegalovirus Immune Globulin Intravenous (Human) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CYTOGAM 85238921 4025755 Dead/Cancelled |
CSL Behring AG 2011-02-10 |
CYTOGAM 77522611 not registered Dead/Abandoned |
CSL Behring AG 2008-07-15 |
CYTOGAM 74178919 1742103 Live/Registered |
SAOL BERMUDA LIMITED 1991-06-21 |